Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Monoclonal antibody targeting the conserved region of the SARS-CoV-2 spike protein to overcome viral variants
Wan-Ling Wu, Chen-Yi Chiang, Szu-Chia Lai, et al.
JCI Insight (2022) Vol. 7, Iss. 8
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

SARS-CoV-2 spike S2-specific neutralizing antibodies
Chia‐Jung Li, Shih‐Chung Chang
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 35
Antigenic evolution of SARS coronavirus 2
Anna Z. Mykytyn, Ron A. M. Fouchier, Bart L. Haagmans
Current Opinion in Virology (2023) Vol. 62, pp. 101349-101349
Open Access | Times Cited: 26
Significance of Conserved Regions in Coronavirus Spike Protein for Developing a Novel Vaccine against SARS-CoV-2 Infection
Titus Abiola Olukitibi, Zhujun Ao, Bryce M. Warner, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 545-545
Open Access | Times Cited: 23
Evolution of Anti-SARS-CoV-2 Therapeutic Antibodies
Juan C. Almagro, Gabriela Mellado‐Sánchez, Martha Pedraza‐Escalona, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9763-9763
Open Access | Times Cited: 29
Comprehensive Overview of Broadly Neutralizing Antibodies against SARS-COV-2 Variants
Lingyan Cui, Tingting Li, Wenhui Xue, et al.
(2024)
Open Access | Times Cited: 6
Overcoming antibody-resistant SARS-CoV-2 variants with bispecific antibodies constructed using non-neutralizing antibodies
Tetsuya Inoue, Yuichiro Yamamoto, Kaoru Sato, et al.
iScience (2024) Vol. 27, Iss. 4, pp. 109363-109363
Open Access | Times Cited: 5
Current Status and Perspectives of Therapeutic Antibodies Targeting the Spike Protein S2 Subunit against SARS-CoV-2
Yuichiro Yamamoto, Tetsuya Inoue
Biological and Pharmaceutical Bulletin (2024) Vol. 47, Iss. 5, pp. 917-923
Open Access | Times Cited: 5
Comprehensive Overview of Broadly Neutralizing Antibodies against SARS-CoV-2 Variants
Lingyan Cui, Tingting Li, Wenhui Xue, et al.
Viruses (2024) Vol. 16, Iss. 6, pp. 900-900
Open Access | Times Cited: 5
Precision arbovirus serology with a pan-arbovirus peptidome
William R. Morgenlander, Wan Ni Chia, Beatriz Parra, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Ultra-Sensitive Aptamer-Based Diagnostic Systems for Rapid Detection of All SARS-CoV-2 Variants
Sang Won Kim, Min Jung Han, Md Shafiqur Rahman, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 745-745
Open Access
A novel neutralizing antibody recognizing a conserved conformational epitope in PDCoV S1 protein and its therapeutic efficacy in piglets
Rui Chen, Guiping Zhou, Junpeng Yang, et al.
Journal of Virology (2025)
Closed Access
A novel microfluidic chip based on an impedance-enhanced electrochemical immunoassay
Sung‐Lin Tsai, Jiunn‐Jye Wey, Szu-Chia Lai, et al.
Physics of Fluids (2025) Vol. 37, Iss. 1
Closed Access
Potent neutralising monoclonal antibodies targeting the spike of NL63 coronavirus
Wen Shi Lee, George Taiaroa, Robyn Esterbauer, et al.
npj Viruses (2025) Vol. 3, Iss. 1
Open Access
Significance of Conserved Regions in Coronavirus Spike Protein for Developing a Novel Vaccine against SARS-Cov-2 Infection
Titus Abiola Olukitibi, Zhujun Ao, Bryce M. Warner, et al.
(2023)
Open Access | Times Cited: 8
Revealing SARS-CoV-2 Mpro Mutation Cold and Hot Spots: Dynamic Residue Network Analysis Meets Machine Learning
Victor Barozi, Shrestha Chakraborty, S. Govender, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 3800-3816
Open Access | Times Cited: 3
Prospective clinical performance of CoVarScan in identifying SARS-CoV-2 Omicron subvariants
Kenneth Zhu, Manoj Kumar Sah, Lenin Mahimainathan, et al.
Microbiology Spectrum (2024)
Open Access | Times Cited: 2
Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that bind a conserved membrane proximal epitope of the spike
Sieglinde De, Inge Van Molle, Loes van Schie, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Lessons from COVID‐19: Aspects of prevention, therapeutics, and diagnostics against SARS‐CoV‐2 with special focus on JN.1 and XBB sublineages
Puja Jaishwal, Upagya Gyaneshwari, Kisalay Jha, et al.
MedComm – Future Medicine (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 1
SARS-CoV-2 spike-FLIPr fusion protein plus lipidated FLIPr protects against various SARS-CoV-2 variants in hamsters
Ming-Shu Hsieh, Chia-Wei Hsu, Hung‐Chun Liao, et al.
Journal of Virology (2024) Vol. 98, Iss. 2
Open Access | Times Cited: 1
S2 Peptide-Conjugated SARS-CoV-2 Virus-like Particles Provide Broad Protection against SARS-CoV-2 Variants of Concern
Chang-Kyu Heo, Won-Hee Lim, Ki-Beom Moon, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 676-676
Open Access | Times Cited: 1
Identification of Various Recombinants in a Patient Coinfected With the Different SARS‐CoV‐2 Variants
Yusuke Sayama, Akie Sakagami, Michiko Okamoto, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 6
Open Access | Times Cited: 1
Induction of high affinity monoclonal antibodies against SARS-CoV-2 variant infection using a DNA prime-protein boost strategy
Chen-Yi Chiang, Mei‐Yu Chen, Chia-Wei Hsu, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 6
Co‐delivery of a trimeric spike DNA and protein vaccine with aluminum hydroxide enhanced Th1‐dominant humoral and cellular immunity against SARS‐CoV‐2
Hung‐Chun Liao, Min‐Syuan Huang, Fang‐Feng Chiu, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 8
Open Access | Times Cited: 2
Sotrovimab in solid organ transplant recipients with COVID-19: a systematic review and meta-analysis
Behnam Amani, Rouhollah Shabestan, Kourosh Rajabkhah, et al.
Korean Journal of Transplantation (2023) Vol. 37, Iss. 4, pp. 277-285
Open Access | Times Cited: 2
Preclinical Evaluation of a Cross-Protective ß-SARS-CoV-2 Virus-Like Particle Vaccine Adjuvanted with MF59
Linda Earnest, Daniel Fernandez‐Ruiz, Melissa A. Edeling, et al.
(2024)
Open Access
Page 1 - Next Page

Scroll to top